Professor Andrew Steer is a Heart Foundation Future Leader Fellow whose research into Rheumatic Heart Disease (RHD) won the 2017 Eureka Prize for Infectious Diseases Research.
I’ve been really lucky in that I’ve had support from the Heart Foundation throughout my research career. That’s been amazing and has allowed me to pursue an independent research career
I can’t describe how important that support has been for me and my team (and) for us to follow our own ideas with independence.
Professor Steer’s heart research is looking at innovative steps to better identify and manage the potentially deadly condition Rheumatic Heart Disease.
Rheumatic Heart Disease is a chronic disease that leads to the damage of one or more heart valves. The condition begins in childhood and is caused by an infection by the bacteria, group A streptococcus.
Rheumatic Heart Disease is a major health problem in Aboriginal and Torres Strait Islander communities. Across the world, the condition affects more than 33 million people living in tropical areas and leads to over 300,000 premature deaths each year.
“One of the big discoveries over the last couple of years was a really key clinical trial that we conducted in Fiji. It speaks to the potential impact of group A strep infection in the skin contributing to Rheumatic Heart Disease,” Professor Steer explains.
“In this trial, we showed that we can prevent up to 95% of these skin infections with a once-a-year treatment.”
“What is really exciting now is to see whether we can take that very simple and inexpensive treatment and run it into larger trials to see if we can also prevent Rheumatic Heart Disease,” Professor Steer says.
By people around Australia contributing to the Heart Foundation, this translates into support for people like me and the work I do and, in that way, directly influences heart research in Australia.
Professor Andrew Steer
Future Leader Fellow
Rheumatic heart disease is a serious disease that causes damage to your heart valves.
Australian guidelines for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease.
Quantifying myocardial inflammation in acute rheumatic fever and rheumatic heart disease
Last updated03 May 2023